Series conclusion Five instalments. Five levels of education. One recurring pattern: the countries that ran the experiment are retreating, the countries that watched them are still paying the entry ...

It is time for the government to move away from the outdated practice of lowest bidding (L1) in public procurement and adopt the globally accepted Quality-cum-Cost-Based Selection (QCBS) method. This ...

In this study, the authors use microCT to image an intact hatchling octopus and segment major organ systems, including the vascular, respiratory, digestive, and nervous systems. The resulting dataset ...

The dorsal raphe nucleus (DRN) serotonergic (5-HT) system has been implicated in regulating sleep and motor control; however, its specific role remains controversial. In this study, we found that ...

The former senator wants to heal the America he’s leaving behind.

How Facebook's 2011 Like button change became the template for 15 years of dark patterns, broken promises, and user trust ...

Anatomy of a Chokepoint: What Twenty Million Barrels of Daily Panic Looks Like The Strait of Hormuz is not a strategic abstraction from a think-tank white paper. It is a sliver of water — 34 ...

In the spring of 2020, the Federal Reserve faced a challenge: The COVID-19 pandemic was upending daily life with shutdowns, social distancing, and heightened uncertainty, but the traditional economic ...

Placebo-adjusted mean weight loss of 16.3% (39 lbs) at 180 mg and 16.0% (37 lbs) at 240 mg at 44 weeks with no evidence of weight loss plateau in ACCESS II, demonstrating highest efficacy among oral ...

A new data structure and compression technique developed by engineers at UC San Diego enables the field of pangenomics to handle unprecedented scales of genetic information. Illustration by Alice ...

Google launched four official and confirmed algorithmic updates in 2025, three core updates and one spam update. This is in comparison to last year, in 2024, where we had seven confirmed updates, then ...

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...